A detailed history of Macquarie Group LTD transactions in Zoetis Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 221,174 shares of ZTS stock, worth $42.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
221,174
Previous 490,069 54.87%
Holding current value
$42.7 Million
Previous $82.9 Million 53.76%
% of portfolio
0.05%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$145.54 - $178.83 $39.1 Million - $48.1 Million
-268,895 Reduced 54.87%
221,174 $38.3 Million
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $2.4 Million - $2.89 Million
-14,474 Reduced 2.87%
490,069 $82.9 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $3.12 Million - $4.13 Million
-20,633 Reduced 3.93%
504,543 $99.6 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $1.81 Million - $2.09 Million
10,840 Added 2.11%
525,176 $91.4 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $60.3 Million - $69.8 Million
-374,598 Reduced 42.14%
514,336 $88.6 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $67.1 Million - $80.7 Million
-461,059 Reduced 34.15%
888,934 $148 Million
Q4 2022

Feb 21, 2023

SELL
$131.14 - $157.47 $1.03 Million - $1.24 Million
-7,865 Reduced 0.58%
1,349,993 $198 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $8.69 Million - $10.7 Million
-58,568 Reduced 4.13%
1,357,858 $201 Million
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $5.08 Million - $6.52 Million
32,591 Added 2.36%
1,416,426 $243 Million
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $19.5 Million - $25.2 Million
-107,734 Reduced 7.22%
1,383,835 $261 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $11.6 Million - $14.8 Million
59,836 Added 4.18%
1,491,569 $364 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $6.37 Million - $7.05 Million
-33,642 Reduced 2.3%
1,431,733 $278 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $198 Million - $238 Million
1,267,799 Added 641.68%
1,465,375 $273 Million
Q1 2021

May 14, 2021

SELL
$144.0 - $169.39 $2.35 Million - $2.77 Million
-16,352 Reduced 7.64%
197,576 $31.1 Million
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $425,973 - $472,837
2,712 Added 1.28%
213,928 $35.4 Million
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $2.64 Million - $3.19 Million
19,260 Added 10.03%
211,216 $34.9 Million
Q2 2020

Aug 11, 2020

BUY
$111.92 - $142.53 $1.54 Million - $1.96 Million
13,724 Added 7.7%
191,956 $26.3 Million
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $768,707 - $1.2 Million
-8,296 Reduced 4.45%
178,232 $21 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $478,252 - $548,190
-4,114 Reduced 2.16%
186,528 $24.7 Million
Q3 2019

Nov 14, 2019

SELL
$112.57 - $128.43 $832,455 - $949,739
-7,395 Reduced 3.73%
190,642 $23.8 Million
Q2 2019

Nov 06, 2019

BUY
$97.98 - $114.28 $18.6 Million - $21.7 Million
189,490 Added 2217.04%
198,037 $22.5 Million
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $18.6 Million - $21.7 Million
-190,228 Reduced 95.7%
8,547 $970,000
Q1 2019

May 15, 2019

SELL
$81.56 - $100.67 $415,956 - $513,417
-5,100 Reduced 2.5%
198,775 $20 Million
Q4 2018

Feb 15, 2019

SELL
$79.28 - $95.27 $558,924 - $671,653
-7,050 Reduced 3.34%
203,875 $17.4 Million
Q3 2018

Nov 15, 2018

SELL
$83.5 - $93.23 $2.35 Million - $2.63 Million
-28,194 Reduced 11.79%
210,925 $19.3 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $2.87 Million - $3.2 Million
-35,869 Reduced 13.04%
239,119 $20.4 Million
Q1 2018

May 11, 2018

SELL
$71.51 - $84.69 $893,875 - $1.06 Million
-12,500 Reduced 4.35%
274,988 $23 Million
Q4 2017

Feb 15, 2018

BUY
$63.24 - $72.8 $13.1 Million - $15 Million
206,500 Added 254.98%
287,488 $20.5 Million
Q3 2017

Nov 08, 2017

BUY
$59.73 - $65.4 $4.84 Million - $5.3 Million
80,988
80,988 $5.16 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $90.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.